EGLN3 and central nervous system cancer: Consistent with our in vitro experiments, a quantitative analysis of total tumor transcript levels indicated that Dox-induced Egln3 reduced Vegf by ≈80%, Klf5 by ≈90% and Oct4 by ≈90% in Rt-gliomas (Figure 6G).